BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18031796)

  • 1. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
    Aberg M; Wickström M; Siegbahn A
    Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
    Jiang X; Guo YL; Bromberg ME
    Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
    Aberg M; Johnell M; Wickström M; Siegbahn A
    Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin reduces the production of prothrombotic prostasomes in human prostate cancer cells.
    Aberg M; Johnell M; Wickström M; Widunder A; Siegbahn A
    Thromb Haemost; 2008 Oct; 100(4):655-62. PubMed ID: 18841289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis.
    Versteeg HH; Spek CA; Richel DJ; Peppelenbosch MP
    Oncogene; 2004 Jan; 23(2):410-7. PubMed ID: 14724569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
    Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR
    Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK.
    Koyuturk M; Ersoz M; Altiok N
    Cancer Lett; 2007 Jun; 250(2):220-8. PubMed ID: 17125918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer].
    Fang J; Wei WN; Xia LH; Song SJ
    Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):143-6. PubMed ID: 15182581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
    Jiang X; Zhu S; Panetti TS; Bromberg ME
    Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of exogenous tissue factor on the regulators of proliferation and apoptosis in endothelial cells.
    Pradier A; Ettelaie C
    J Vasc Res; 2008; 45(1):19-32. PubMed ID: 17898544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor.
    Muth H; Kreis I; Zimmermann R; Tillmanns H; Hölschermann H
    Thromb Haemost; 2005 Nov; 94(5):1028-34. PubMed ID: 16363246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.
    Konturek PC; Burnat G; Hahn EG
    J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():141-8. PubMed ID: 17901590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
    Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
    Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway.
    Lee JH; Li YC; Ip SW; Hsu SC; Chang NW; Tang NY; Yu CS; Chou ST; Lin SS; Lino CC; Yang JS; Chung JG
    Anticancer Res; 2008; 28(3A):1701-11. PubMed ID: 18630529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-dependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma.
    Woodard J; Sassano A; Hay N; Platanias LC
    Clin Cancer Res; 2008 Jul; 14(14):4640-9. PubMed ID: 18628479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Yokota K; Miyoshi F; Miyazaki T; Sato K; Yoshida Y; Asanuma Y; Akiyama Y; Mimura T
    J Rheumatol; 2008 Feb; 35(2):193-200. PubMed ID: 18203325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin suppresses homocysteine-induced apoptosis in endothelial cells: roles of caspase-3, cIAP-1 and cIAP-2.
    Xu Z; Lu G; Wu F
    Hypertens Res; 2009 May; 32(5):375-80. PubMed ID: 19343037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.